Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 56 results.
User Information
Export Records
  1. 1.   Antiretroviral Therapy within Two Years of HIV Acquisition is Associated with Fewer Viral Blips: A Retrospective Analysis of Over 20 Years of Data from the U.S. Military HIV Natural History Study
  2. Crowell, Trevor A; Hsieh, Hsing-Chuan; Wang, Xun; Chu, Xiuping; Gayle, Britt; Berjohn, Catherine M; Blaylock, Jason M; Yabes, Joseph M; Larson, Derek T; Powers,John; O'Connell, Robert J; Ganesan, Anuradha; Agan, Brian K
  3. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2025, Mar 10;
  1. 2.   Plasma SARS-CoV-2 RNA levels as a biomarker of lower respiratory tract SARS-CoV-2 infection in critically ill patients with COVID-19
  2. Jacobs, Jana L; Naqvi, Asma; Shah, Faraaz A; Boltz,Valerie; Kearney,Mary; McVerry, Bryan J; Ray, Prabir; Schaefer, Caitlin; Fitzpatrick, Meghan; Methé, Barbara; Lee, Janet S; Morris, Alison; Mellors, John W; Kitsios, Georgios D; Bain, William
  3. The Journal of Infectious Diseases. 2022, May 02;
  1. 3.   Clonal Expansion of Infected CD4+T Cells in People Living with HIV
  2. Coffin, John M.; Hughes, Stephen H.
  3. Viruses. 2021, Oct 15; 13(10):
  1. 4.   Prevalence and risk of residual viremia after ART in low- and middle-income countries A cross-sectional study
  2. Gatechompol, Sivaporn; Zheng, Lu; Bao, Yajing; Avihingsanon, Anchalee; Kerr, Stephen J.; Kumarasamy, Nagalingeswaran; Hakim, James G.; Maldarelli,Frank; Gorelick,Robert; Welker,Jorden; Lifson,Jeffrey; Hosseinipour, Mina C.; Eron, Joseph J.; Ruxrungtham, Kiat
  3. Medicine (Baltimore). 2021, Sep 3; 100(35):
  1. 5.   HIV Viremia Is Associated With APOL1 Variants and Reduced JC-Viruria
  2. Kruzel-Davila, Etty; Sankofi, Barbara Mensah; Kubi Amos-Abanyie, Ernestine; Ghansah, Anita; Nyarko, Alexander; Agyemang, Seth; Awandare, Gordon A; Szwarcwort-Cohen, Moran; Reiner-Benaim, Anat; Hijazi, Basem; Ulasi, Ifeoma; Raji, Yemi Raheem; Boima, Vincent; Osafo, Charlotte; May Adabayeri, Victoria; Matekole, Michael; Olanrewaju, Timothy O; Ajayi, Samuel; Mamven, Manmak; Antwi, Sampson; Ademola, Adebowale D; Plange-Rhule, Jacob; Arogundade, Fatiu; Akyaw, Priscilla Abena; Winkler,Cheryl; Salako, Babatunde L; Ojo, Akinlolu; Skorecki, Karl; Adu, Dwomoa
  3. Frontiers in Medicine. 2021, Aug 27; 8: 718300.
  1. 6.   Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes
  2. Jacobs, Jana L; Bain, William; Naqvi, Asma; Staines, Brittany; Castanha, Priscila M S; Yang, Haopu; Boltz,Valerie; Barratt-Boyes, Simon; Marques, Ernesto T A; Mitchell, Stephanie L; Methé, Barbara; Olonisakin, Tolani F; Haidar, Ghady; Burke, Thomas W; Petzold, Elizabeth; Denny, Thomas; Woods, Chris W; McVerry, Bryan J; Lee, Janet S; Watkins, Simon C; St Croix, Claudette M; Morris, Alison; Kearney,Mary; Ladinsky, Mark S; Bjorkman, Pamela J; Kitsios, Georgios; Mellors, John W
  3. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021, Aug 10; 74(9): 1525-1533.
  1. 7.   Characterizing the Latent HIV-1 Reservoir in Patients with Viremia Suppressed on cART: Progress, Challenges, and Opportunities
  2. Rausch,Jason; Le Grice,Stuart
  3. Current HIV research. 2020, Dec 30; 18(2): 99-113.
  1. 8.   Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques
  2. Virnik, Konstantin; Rosati,Margherita; Medvedev, Alexei; Scanlan, Aaron; Walsh, Gabrielle; Dayton, Frances; Broderick, Kate E; Lewis, Mark; Bryson, Yvonne; Lifson,Jeffrey; Ruprecht, Ruth M; Felber,Barbara; Berkower, Ira
  3. PloS one. 2020, MAR 4; 15(3): e0228163.
  1. 9.   Tandem Orthotopic Living Donor Liver Transplantation Followed by Same Donor Haploidentical Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency: Tandem Liver and Bone Marrow Transplant in DOCK8 Deficiency
  2. Freeman, Alexandra F; Yazigi, Nada; Shah, Nirali N; Kleiner, David E; Parta, Mark; Atkinson, Prescott; Heller, Theo; Holland, Steven M; Kaufman, Stuart S; Khan, Khalid M; Hickstein, Dennis D
  3. Transplantation. 2019, OCT; 103(10): 2144-2149.
  1. 10.   Predicting the broadly neutralizing antibody susceptibility of the HIV reservoir
  2. Yu, Wen-Han; Su, David; Torabi, Julia; Fennessey,Christine; Shiakolas, Andrea; Lynch, Rebecca; Chun, Tae-Wook; Doria-Rose, Nicole; Alter, Galit; Seaman, Michael S; Keele,Brandon; Lauffenburger, Douglas A; Julg, Boris
  3. JCI insight. 2019, Sep 05; 4(17): pii: 130153.
  1. 11.   Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model
  2. Anthony-Gonda, Kim; Bardhi, Ariola; Ray, Alex; Flerin, Nina; Li, Mengyan; Chen, Weizao; Ochsenbauer, Christina; Kappes, John C; Krueger, Winfried; Worden, Andrew; Schneider, Dina; Zhu, Zhongyu; Orentas, Rimas; Dimitrov, Dimiter S; Goldstein, Harris; Dropulic, Boro
  3. Science translational medicine. 2019, Aug 07; 11(504): pii: eaav5685..
  1. 12.   Clonal expansion of SIV-infected cells in macaques on antiretroviral therapy is similar to that of HIV-infected cells in humans
  2. Ferris,Andrea; Wells, David W; Guo, Shuang; Del Prete,Greg; Swanstrom,Adrienne; Coffin, John M; Wu,Xiaolin; Lifson,Jeffrey; Hughes,Stephen
  3. PLoS pathogens. 2019, Jul; 15(7): e1007869.
  1. 13.   No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1-Infected Patients Receiving Antiretroviral Therapy
  2. Gandhi, R. T.; Coombs, R. W.; Chan, E. S.; Bosch, R. J.; Zheng, L.; Margolis, D. M.; Read, S.; Kallungal, B.; Chang, M.; Goecker, E. A.; Wiegand, A.; Kearney, M.; Jacobson, J. M.; D'Aquila, R.; Lederman, M. M.; Mellors, J. W.; Eron, J. J.; AIDS Clinical Trials Group (ACTG) A5244 Team
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2012, Mar; 59(3): 229-235.
  1. 14.   SIVmac251 Is Inefficiently Transmitted to Rhesus Macaques by Penile Inoculation with a Single SIVenv Variant Found in Ramp-up Phase Plasma
  2. Ma, Z. M.; Keele, B. F.; Qureshi, H.; Stone, M.; DeSilva, V.; Fritts, L.; Lifson, J. D.; Miller, C. J.
  3. Aids Research and Human Retroviruses. 2011, Dec; 27(12): 1259-1269.
  1. 15.   Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
  2. Koelsch, K. K.; Boesecke, C.; McBride, K.; Gelgor, L.; Fahey, P.; Natarajan, V.; Baker, D.; Bloch, M.; Murray, J. M.; Zaunders, J.; Emery, S.; Cooper, D. A.; Kelleher, A. D.; Team, P. S.
  3. Aids. 2011, Nov; 25(17): 2069-2078.
  1. 16.   Clonal Sequences Recovered from Plasma from Patients with Residual HIV-1 Viremia and on Intensified Antiretroviral Therapy Are Identical to Replicating Viral RNAs Recovered from Circulating Resting CD4(+) T Cells
  2. Anderson, J. A.; Archin, N. M.; Ince, W.; Parker, D.; Wiegand, A.; Coffin, J. M.; Kuruc, J.; Eron, J.; Swanstrom, R.; Margolis, D. M.
  3. Journal of Virology. 2011, May; 85(10): 5220-5223.
  1. 17.   Factors Associated With Viral Rebound in HIV-1-Infected Individuals Enrolled in a Therapeutic HIV-1 gag Vaccine Trial
  2. Li, J. Z.; Brumme, Z. L.; Brumme, C. J.; Wang, H. Y.; Spritzler, J.; Robertson, M. N.; Lederman, M. M.; Carrington, M.; Walker, B. D.; Schooley, R. T.; Kuritzkes, D. R.; AIDS Clinical Trials Group (ACTG) A5197 Team
  3. Journal of Infectious Diseases. 2011, Apr; 203(7): 976-983.
  1. 18.   HIV-1 viruses detected during episodic blips following interleukin-7 administration are similar to the viruses present before and after interleukin-7 therapy
  2. Imamichi, H.; DeGray, G.; Asmuth, D. M.; Fischl, M. A.; Landay, A. L.; Lederman, M. M.; Sereti, I.
  3. Aids. 2011, Jan; 25(2): 159-164.
  1. 19.   Genetic Diversity of Simian Immunodeficiency Virus Encoding HIV-1 Reverse Transcriptase Persists in Macaques despite Antiretroviral Therapy
  2. Kearney, M.; Spindler, J.; Shao, W.; Maldarelli, F.; Palmer, S.; Hu, S. L.; Lifson, J. D.; KewalRamani, V. N.; Mellors, J. W.; Coffin, J. M.; Ambrose, Z.
  3. Journal of Virology. 2011, Jan; 85(2): 1067-1076.
  1. 20.   An Antiretroviral/Zinc Combination Gel Provides 24 Hours of Complete Protection against Vaginal SHIV Infection in Macaques
  2. Kenney, J.; Aravantinou, M.; Singer, R.; Hsu, M.; Rodriguez, A.; Kizima, L.; Abraham, C. J.; Menon, R.; Seidor, S.; Chudolij, A.; Gettie, A.; Blanchard, J.; Lifson, J. D.; Piatak, M.; Fernandez-Romero, J. A.; Zydowsky, T. M.; Robbiani, M.
  3. Plos One. 2011, Jan; 6(1): 10.
  1. 21.   HIV-1 Continues To Replicate and Evolve in Patients with Natural Control of HIV Infection
  2. Mens, H.; Kearney, M.; Wiegand, A.; Shao, W.; Schonning, K.; Gerstoft, J.; Obel, N.; Maldarelli, F.; Mellors, J. W.; Benfield, T.; Coffin, J. M.
  3. Journal of Virology. 2010, Dec; 84(24): 12971-12981.
  1. 22.   Short-Course Raltegravir Intensification Does Not Reduce Persistent Low-Level Viremia in Patients with HIV-1 Suppression during Receipt of Combination Antiretroviral Therapy
  2. McMahon, D.; Jones, J.; Wiegand, A.; Gange, S. J.; Kearney, M.; Palmer, S.; McNulty, S.; Metcalf, J. A.; Acosta, E.; Rehm, C.; Coffin, J. M.; Mellors, J. W.; Maldarelli, F.
  3. Clinical Infectious Diseases. 2010, Mar; 50(6): 912-919.
  1. 23.   High Specific Infectivity of Plasma Virus from the Pre-Ramp-Up and Ramp-Up Stages of Acute Simian Immunodeficiency Virus Infection
  2. Ma, Z. M.; Stone, M.; Piatak, M.; Schweighardt, B.; Haigwood, N. L.; Montefiori, D.; Lifson, J. D.; Busch, M. P.; Miller, C. J.
  3. Journal of Virology. 2009 83(7): 3288-3297.
  1. 24.   Defective Plasmacytoid Dendritic Cell-NK Cell Cross-Talk in HIV Infection
  2. Reitano, K. N.; Kottilil, S.; Gille, C. M.; Zhang, X.; Yan, M.; O'Shea, M. A.; Roby, G.; Hallahan, C. W.; Yang, J.; Lempicki, R. A.; Arthos, J.; Fauci, A. S.
  3. Aids Research and Human Retroviruses. 2009 25(10): 1029-1037.
  1. 25.   Human Immunodeficiency Virus Type 1-Specific CD8(+) T-Cell Responses during Primary Infection Are Major Determinants of the Viral Set Point and Loss of CD4(+) T Cells
  2. Streeck, H.; Jolin, J. S.; Qi, Y.; Yassine-Diab, B.; Johnson, R. C.; Kwon, D. S.; Addo, M. M.; Brumme, C.; Routy, J. P.; Little, S.; Jessen, H. K.; Kelleher, A. D.; Hecht, F. M.; Sekaly, R. P.; Rosenberg, E. S.; Walker, B. D.; Carrington, M.
  3. Journal of Virology. 2009 83(15): 7641-7648.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel